Recursion Pharmaceuticals (RXRX.MX) Q4 2024 Earnings

6NovConfirmed
Q4 2024
-6.87
-6.82
-6.78
-6.73

Details

Expected EPS
-6.72830945025
Actual EPS
-6.873151000000001
Surprise EPS
-0.14
Surprise Percent
+2.15%

Description

Recursion Pharmaceuticals (RXRX.MX) has reported earnings of -6.873151000000001 per share for Q4 2024.

0 Comments

Share your thoughts